U.S. top court rejects Maryland bid to revive drug price-gouging law
The U.S. Supreme Court on Tuesday rejected Maryland's bid to revive a law aimed at preventing price gouging by pharmaceutical companies, dealing a setback to the power of states to rein in prescription drug costs.
from Reuters: Health News https://reut.rs/2Ix6eXU
http://bit.ly/2zwRqiM
February 19, 2019
|
Labels:
health,
Reuters: Health News
|
This entry was posted on February 19, 2019
and is filed under
health
,
Reuters: Health News
.
You can follow any responses to this entry through
the RSS 2.0 feed.
or trackback from your own site.